Strategy for effective brain drug delivery

Prions

Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373 · see citing works

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works

Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.

Diatchenko, L. B., Lau, Y. C., Campbell, A. P., Chenchik, A. A., Moqadam, F., Huang, B. C. B., Lukyanov, S., Lukyanov, K. A., Gurskaya, N. G., Sverdlov, E. D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6025 · Cited by 3,009 · see citing works

The blood-brain barrier/neurovascular unit in health and disease

Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · see citing works

In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse

Schwarze, S. R., Ho, A. L., Vocero-Akbani, A. M., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,418 · see citing works

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R. G., Vick, N. A., Black, K. L., Sisti, M. B., Brem, S. S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,390 · see citing works

Blood–brain barrier delivery

Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191 · see citing works

Extracellular space structure revealed by diffusion analysis

Nicholson, C., & Syková, E. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01261-2 · Cited by 914 · see citing works

Liposomal Drug Delivery Systems: An Update Review

Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 909 · see citing works

Transport of drugs from the nasal cavity to the central nervous system

Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907 · see citing works

Blood-brain barrier active efflux transporters: ATP-binding cassette gene family

Löscher, W., & Potschka, H. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.86 · Cited by 873 · see citing works

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

Nutt, J. G., Burchiel, K. J., Comella, C., Jankovic, J. J., Lang, A. E., Laws, E. R., Lozano, A. M., Penn, R. D., Simpson, R. K., Stacy, M. A., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.69 · Cited by 816 · see citing works

The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction

Engelhardt, B., & Sorokin, L. M. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0177-0 · Cited by 792 · see citing works

Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability

Lockman, P. R., Koziara, J. M., Mumper, R. J., & Allen, D. D. (2004) · Journal of drug targeting · doi:10.1080/10611860400015936 · Cited by 742 · see citing works

Nanoparticles for direct nose-to-brain delivery of drugs

Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734 · see citing works

Role of nanotechnology in targeted drug delivery and imaging: a concise review

Koo, O. M. Y., Rubinstein, I., & Önyüksel, H. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2005.06.004 · Cited by 718 · see citing works

BLOOD-BRAIN BARRIER DRUG TARGETING: THE FUTURE OF BRAIN DRUG DEVELOPMENT

Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 713 · see citing works

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities

Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679 · see citing works

Differentiation of endothelium

Risau, W. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615161 · Cited by 612 · see citing works

Intranasal delivery: Physicochemical and therapeutic aspects

Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598 · see citing works

Therapeutic applications of lipid-coated microbubbles

Unger, E. C., Porter, T. R., Culp, W. C., LaBell, R., Matsunaga, T. O., & Zutshi, R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.006 · Cited by 591 · see citing works

Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521 · see citing works

Electrical resistance of brain microvascular endothelium

Crone, C., & Olesen, S. P. (1982) · Brain Research · doi:10.1016/0006-8993(82)91227-6 · Cited by 491 · see citing works

Delivery of peptides and proteins through the blood–brain barrier

Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 482 · see citing works

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain

Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 475 · see citing works

Restoration of neural output from a paralyzed patient by a direct brain connection

Kennedy, P. R., & Bakay, R. A. E. (1998) · Neuroreport · doi:10.1097/00001756-199806010-00007 · Cited by 475 · see citing works

Pericytes: Cell Biology and Pathology

Allt, G., & Lawrenson, J. G. (2001) · Cells Tissues Organs · doi:10.1159/000047855 · Cited by 455 · see citing works

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone

Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435 · see citing works

Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles

Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, E. S., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434 · see citing works

Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications

Rapoport, S. I. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007049806660 · Cited by 428 · see citing works

Transport of Amino Acid-Related Compounds Mediated by L-Type Amino Acid Transporter 1 (LAT1): Insights Into the Mechanisms of Substrate Recognition

Uchino, H., Kanai, Y., Kim, D. K., Wempe, M. F., Chairoungdua, A., Morimoto, E., Anders, M. W., & Endou, H. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.4.729 · Cited by 421 · see citing works

Drug and Gene Delivery to the Brain

Pardridge, W. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01054-1 · Cited by 405 · see citing works

Nanogels for Oligonucleotide Delivery to the Brain

Vinogradov, S. V., Batrakova, E. V., & Kabanov, A. V. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034164r · Cited by 379 · see citing works

Intrathecal drug spread

Hocking, G., & Wildsmith, J. A. W. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh204 · Cited by 367 · see citing works

Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352 · see citing works

Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate

Pardridge, W. M., Kang, Y., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 317 · see citing works

Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting

Wang, X., Chi, N., & Tang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.005 · Cited by 307 · see citing works

Pharmacokinetics of long-circulating liposomes

Allen, T. M., Hansen, C. B., & de Menezes, D. E. L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00029-7 · Cited by 306 · see citing works

Pharmacokinetics of the Carmustine Implant

Fleming, A. B., & Saltzman, W. M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241060-00002 · Cited by 288 · see citing works

Delivery of peptide and protein drugs over the blood–brain barrier

Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279 · see citing works

Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles

WILSON, B., Samanta, M. K., Santhi, K., KUMAR, K., Paramakrishnan, N., & Suresh, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.009 · Cited by 279 · see citing works

Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier

Schröeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275 · see citing works

Brain-specific expression of an exogenous gene after i.v. administration

Shi, N., Zhang, Y., Zhu, C., Boado, R. J., & Pardridge, W. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221450098 · Cited by 273 · see citing works

The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338)

Illum, L., & Davis, S. S. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)80836-4 · Cited by 267 · see citing works

Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations

Vyas, T. K., Shahiwala, A., & Amiji, M. M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.016 · Cited by 264 · see citing works

Nasal Drug Administration: Potential for Targeted Central Nervous System Delivery

Graff, C. L., & Pollack, G. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20318 · Cited by 261 · see citing works

Ultrasound for drug and gene delivery to the brain

Hynynen, K. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.010 · Cited by 251 · see citing works

Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

Attenello, F. J., Mukherjee, D. R., Datoo, G., McGirt, M. J., Bohan, E. M., WEINGART, J. D., Olivi, A., Quiñones‐Hinojosa, A., & Brem, H. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0048-2 · Cited by 245 · see citing works

Molecular and cellular permeability control at the blood-brain barrier

Gloor, S. M., Wachtel, M., Bolliger, M. F., Ishihara, H., Landmann, R., & Frei, K. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00102-3 · Cited by 244 · see citing works

Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS

Dou, H., Grotepas, C. B., McMillan, J., Destache, C. J., Chaubal, M. V., Werling, J. O., Kipp, J., Rabinow, B. E., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 238 · see citing works

Physiology and pharmacological role of the blood-brain barrier.

Bernacki, J., Dobrowolska, A., Nierwińska, K., & Małecki, A. (2008) · PubMed · Cited by 234 · see citing works

Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting

Brigger, I., Morizet, J., Aubert, G., Chacun, H., Terrier‐Lacombe, M., Couvreur, P., & Vassal, G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039669 · Cited by 234 · see citing works

Targeting the central nervous system: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123

Tosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.022 · Cited by 234 · see citing works

Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo

Vykhodtseva, N. I., Hynynen, K., & Damianou, C. (1995) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(95)00038-s · Cited by 230 · see citing works

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80–coated polybutylcyanoacrylate nanoparticles: Anin situbrain perfusion study

Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229 · see citing works

The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier

Barbu, E., Molnar, E. M., Tsibouklis, J., & Górecki, D. C. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902939143 · Cited by 229 · see citing works

Folate-Mediated Targeting of Therapeutic and Imaging Agents to Cancers

Reddy, J. A., & Low, P. S. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i6.20 · Cited by 223 · see citing works

Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals

Gabizón, A., Goren, D., Horowitz, A. T., Tzemach, D., Lossos, A., & Siegal, T. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00476-0 · Cited by 220 · see citing works

Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion

Prinz, M., Heikenwälder, M. F., Junt, T., Schwarz, P., Glatzel, M., Heppner, F. L., Fu, Y., Lipp, M., & Aguzzi, A. (2003) · Nature · doi:10.1038/nature02072 · Cited by 217 · see citing works

Chemotherapeutic Drugs Released from Polymers: Distribution of 1,3-bis(2-chloroethyl)-l-nitrosourea in the Rat Brain

Fung, L. K., Shin, M., Tyler, B., Brem, H., & Saltzman, W. M. (1996) · Pharmaceutical Research · doi:10.1023/a:1016083113123 · Cited by 213 · see citing works

Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice

Reddy, L. H., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. S. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.028 · Cited by 212 · see citing works

Intrinsically Fluorescent Carbon Nanospheres as a Nuclear Targeting Vector: Delivery of Membrane-Impermeable Molecule to Modulate Gene Expression In Vivo

Selvi, B. R., Jagadeesan, D., Suma, B. S., Nagashankar, G., Arif, M., Balasubramanyam, K., Eswaramoorthy, M., & Kundu, T. K. (2008) · Nano Letters · doi:10.1021/nl801503m · Cited by 212 · see citing works

Sensory circumventricular organs: central roles in integrated autonomic regulation

Cottrell, G. T., & Ferguson, A. V. (2003) · Regulatory Peptides · doi:10.1016/j.regpep.2003.09.004 · Cited by 210 · see citing works

Drug transport to brain with targeted liposomes

Schnyder, A., & Huwyler, J. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.99 · Cited by 210 · see citing works

Biodegradable polymer implants to treat brain tumors

Brem, H., & Gabikian, P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00311-x · Cited by 192 · see citing works

Basic Fibroblast Growth Factor Prevents Thalamic Degeneration after Cortical Infarction

Yamada, K., Kinoshita, A., Kohmura, E., Sakaguchi, T., Taguchi, J., Kataoka, K., & Hayakawa, T. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.90 · Cited by 188 · see citing works

From nose to brain: understanding transport capacity and transport rate of drugs

Wu, H., Hu, K., & Jiang, X. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.10.1159 · Cited by 188 · see citing works

Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles

Pan, J., & Feng, S.-S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.02.020 · Cited by 187 · see citing works

MRI investigation of the threshold for thermally induced blood–brain barrier disruption and brain tissue damage in the rabbit brain

McDannold, N. J., Vykhodtseva, N. I., Jolesz, F. A., & Hynynen, K. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20060 · Cited by 185 · see citing works

Drug delivery to brain via the blood–brain barrier

Scherrmann, J. M. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00202-1 · Cited by 184 · see citing works

Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles

Wang, J.-X., Sun, X., & Zhang, Z.-R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00083-8 · Cited by 179 · see citing works

Global non-viral gene transfer to the primate brain following intravenous administration

Zhang, Y., Schlachetzki, F., & Pardridge, W. M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00018-7 · Cited by 179 · see citing works

Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting

Kumar, M., Misra, A., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802476504 · Cited by 179 · see citing works

Blood−brain barrier transporters and response to CNS-active drugs

Urquhart, B. L., & Kim, R. B. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0714-8 · Cited by 175 · see citing works

Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating

MacKay, J. A., Deen, D. F., & Szoka, F. C. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.007 · Cited by 172 · see citing works

Conjugation of brain-derived neurotrophic factor to a blood–brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin

Zhang, Y., & Pardridge, W. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03108-5 · Cited by 167 · see citing works

Development of microspheres for neurological disorders: From basics to clinical applications

Benoît, J., Faisant, N., Venier‐Julienne, M., & Meneï, P. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00250-3 · Cited by 166 · see citing works

Blood—Brain Barrier Genomics

Li, J. Y., Boado, R. J., & Pardridge, W. M. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200101000-00008 · Cited by 164 · see citing works

A Direct In Vitro Demonstration of Insulin Binding to Isolated Brain Microvessels

Frank, H. J. L., & Pardridge, W. M. (1981) · Diabetes · doi:10.2337/diab.30.9.757 · Cited by 164 · see citing works

Local drug delivery to the brain

Wang, P. P., Frazier, J., & Brem, H. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00054-6 · Cited by 161 · see citing works

Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems

Bodor, N. S., & Buchwald, P. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00090-8 · Cited by 158 · see citing works

Human blood-brain barrier insulin-like growth factor receptor

Duffy, K. R., Pardridge, W. M., & Rosenfeld, R. G. (1988) · Metabolism · doi:10.1016/s0026-0495(98)90007-5 · Cited by 158 · see citing works

Electrical resistance of a capillary endothelium.

Crone, C. G., & Christensen, O. (1981) · The Journal of General Physiology · doi:10.1085/jgp.77.4.349 · Cited by 157 · see citing works

Disruption of Astrocyte STAT3 Signaling Decreases Mitochondrial Function and Increases Oxidative Stress In Vitro

Sarafian, T. A., Montes, C., Imura, T., Qi, J., Coppola, G., Geschwind, D. H., & Sofroniew, M. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009532 · Cited by 153 · see citing works

The Role of the Choroid Plexus in Neutrophil Invasion after Traumatic Brain Injury

Szmydynger‐Chodobska, J., Strazielle, N., Zink, B. J., Ghersi‐Egea, J., & Chodobski, A. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.71 · Cited by 151 · see citing works

Development of neuropeptide drugs that cross the blood-brain barrier

Egleton, R. D., & Davis, T. P. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.44 · Cited by 151 · see citing works

Plasma and Cerebrospinal Fluid Pharmacokinetics of Intravenous Temozolomide in Non-human Primates

Patel, M. C., McCully, C. L., Godwin, K., et al. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022592913323 · Cited by 150 · see citing works

Use of Ultrasound Pulses Combined with Definity for Targeted Blood-Brain Barrier Disruption: A Feasibility Study

McDannold, N. J., Vykhodtseva, N. I., & Hynynen, K. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.10.004 · Cited by 150 · see citing works

Bioavailability and Transport of Peptides and Peptide Drugs into the Brain

Egleton, R. D., & Davis, T. P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00242-8 · Cited by 150 · see citing works

Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles

Alyautdin, R. N., Gothier, D., Петров, Kharkevich, D. A., & Kreuter, J. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 148 · see citing works

Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution

Vergoni, A. V., Tosi, G., Tacchi, R., Vandelli, M. A., Bertolini, A., & Costantino, L. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.02.005 · Cited by 147 · see citing works

Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach

Pavan, B., Dalpiaz, A., Ciliberti, N., Biondi, C., Manfredini, S., & Vertuani, S. (2008) · Molecules · doi:10.3390/molecules13051035 · Cited by 145 · see citing works

Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport

Borlongan, C. V., & Emerich, D. F. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00043-1 · Cited by 137 · see citing works

Drug delivery to damaged brain

Lo, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00083-2 · Cited by 136 · see citing works

The Human Brain GLUT1 Glucose Transporter: Ultrastructural Localization to the Blood—Brain Barrier Endothelia

Cornford, E. M., Hyman, S., & Swartz, B. E. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.15 · Cited by 136 · see citing works

Effect of global system for mobile communication (GSM) microwave exposure on blood-brain barrier permeability in rat

Fritze, K., Sommer, C., Schmitz, B., et al. (1997) · Acta Neuropathologica · doi:10.1007/s004010050734 · Cited by 131 · see citing works

Potential of Nanoparticulate Drug Delivery Systems by Intranasal Administration

Ali, J., Ali, M., Baboota, S., Sahni, J. K., Ramassamy, C., Dao, L. H., & Bhavna (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791164108 · Cited by 130 · see citing works

Cytotoxicity and Apoptosis Enhancement in Brain Tumor Cells Upon Coadministration of Paclitaxel and Ceramide in Nanoemulsion Formulations

Desai, A. R., Vyas, T. K., & Amiji, M. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21182 · Cited by 128 · see citing works

Enhanced Prospects for Drug Delivery and Brain Targeting by the Choroid Plexus–CSF Route

Johanson, C. E., Duncan, J. A., Stopa, E. G., & Baird, A. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6039-0 · Cited by 128 · see citing works

Gum Arabic-Coated Magnetic Nanoparticles for Potential Application in Simultaneous Magnetic Targeting and Tumor Imaging

Zhang, L., Yu, F., Cole, A. J., Chertok, B., David, A. E., Wang, J., & Yang, V. C.-M. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9151-y · Cited by 128 · see citing works

Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma.

Napier, M. P., Sharma, S., Springer, C. J., et al. (2000) · PubMed · Cited by 128 · see citing works

Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin–biotin technology: Formulation development and in vitro anticancer activity

Pulkkinen, M., Pikkarainen, J. T., Wirth, T., TARVAINEN, T., Haapa‐aho, V., KORHONEN, H., Seppälä, J. V., & Järvinen, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.04.018 · Cited by 124 · see citing works

Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia

Ying, W. (2006) · Frontiers in bioscience · doi:10.2741/2267 · Cited by 123 · see citing works

Membrane transporter proteins: a challenge for CNS drug development

Girardin, F. R. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.3/fgirardin · Cited by 122 · see citing works

Differential expression of Na,K-ATPase alpha and beta subunit isoforms at the blood-brain barrier and the choroid plexus.

Zloković, B. V., Mačkić, J. B., Wang, L., McComb, J. G., & McDonough, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53058-1 · Cited by 117 · see citing works

Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan

Vyas, T. K., Babbar, A. K., Sharma, R. K., Singh, S. S., & Misra, A. R. (2006) · AAPS PharmSciTech · doi:10.1208/pt070108 · Cited by 116 · see citing works

Modulation of Brain Tumor Capillaries for Enhanced Drug Delivery Selectively to Brain Tumor

Black, K. L., & Ningaraj, N. S. (2004) · Cancer Control · doi:10.1177/107327480401100304 · Cited by 115 · see citing works

Delivery of Galanin-Like Peptide to the Brain: Targeting with Intranasal Delivery and Cyclodextrins

Nonaka, N., Farr, S. A., Kageyama, H., Shioda, S., & Banks, W. A. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132381 · Cited by 114 · see citing works

The Development of the Bradykinin Agonist Labradimil as a Means to Increase the Permeability of the Blood-Brain Barrier

Emerich, D. F., Dean, R. L., Osborn, C., & Bartus, R. T. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140020-00003 · Cited by 112 · see citing works

Solid lipid nanoparticles of temozolomide: Potential reduction of cardial and nephric toxicity

Huang, G., Zhang, N., Bi, X., & Dou, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.013 · Cited by 112 · see citing works

Barriers to carrier mediated drug and gene delivery to brain tumors

Huynh, G. H., Deen, D. F., & Szoka, F. C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.053 · Cited by 111 · see citing works

Activation of prodrugs by antibody‐enzyme conjugates: a new approach to cancer therapy

Senter, P. D. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.2.2404820 · Cited by 110 · see citing works

Local Chemotherapy with Cisplatin-depot for Glioblastoma Multiforme

Sheleg, S. V., Korotkevich, E. A., Zhavrid, E. A., et al. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1020288015457 · Cited by 109 · see citing works

The blood-brain barrier and neurotherapeutics

Pardridge, W. M. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.1 · Cited by 108 · see citing works

Antibody-Enzyme Conjugates for Cancer Therapy

Melton, R., & Sherwood, R. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.153 · Cited by 104 · see citing works

Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood–brain barrier without inducing reactive gliosis

Rabchevsky, A. G., Degos, J., & Dreyfus, P. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01479-1 · Cited by 102 · see citing works

Transfer of Dopamine in the Olfactory Pathway Following Nasal Administration in Mice

Dahlin, M., Bergman, U., Jansson, B., Björk, E., & Brittebo, E. B. (2000) · Pharmaceutical Research · doi:10.1023/a:1007542618378 · Cited by 99 · see citing works

A lymphotropic prodrug of L-dopa: synthesis, pharmacological properties and pharmacokinetic behavior of 1,3-dihexadecanoyl-2-[(S)-2-amino-3-(3,4-dihydroxyphenyl)propanoyl]propane-1,2,3-triol

Garzon-Aburbeh, A., Poupaert, J. H., Claesen, M. H., et al. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00155a018 · Cited by 99 · see citing works

Clinical Pharmacology of Encapsulated Sustained-Release Cytarabine

Murry, D. J., & Blaney, S. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19347 · Cited by 98 · see citing works

Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents

Westin, U., Piras, E., Jansson, B., Bergström, U., Dahlin, M., Brittebo, E. B., & Björk, E. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.009 · Cited by 96 · see citing works

Peptide-based drug design, controlling transport and metabolism

Vollmar, A. M. (1996) · Toxicon · doi:10.1016/0041-0101(96)83842-6 · Cited by 96 · see citing works

The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats

Zhang, Q., Zha, L., Zhang, Y., Jiang, W.-M., Lü, W., Shi, Z., Jiang, X., & Fu, S. (2006) · Journal of drug targeting · doi:10.1080/10611860600721051 · Cited by 87 · see citing works

Structural changes in the rat brain after carotid infusions of hyperosmolar solutions

Salahuddin, T. S., Johansson, B. B., Kalimo, H., & Olsson, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00688236 · Cited by 85 · see citing works

Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administration

Groothuis, D. R., Benalcazar, H., Allen, C. V., Wise, R. M., Dills, C. V., Dobrescu, C., Rothholtz, V. S., & Levy, R. M. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02089-2 · Cited by 83 · see citing works

Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis

Kizelsztein, P., Ovadia, H., Garbuzenko, O. B., et al. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.05.019 · Cited by 82 · see citing works

Direct Nose-to-Brain Transfer of Morphine After Nasal Administration to Rats

Westin, U. E., Boström, E., Gråsjö, J., Hammarlund‐Udenaes, M., & Björk, E. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9534-z · Cited by 81 · see citing works

Preparation and Therapeutic Efficacy of Polysorbate-80-Coated Amphotericin B/PLA-b-PEG Nanoparticles

Ren, T., Xu, N., Cao, C., Yuan, W., Xiao, Y., Chen, J., & Ren, J. (2009) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/092050609x12457418779185 · Cited by 80 · see citing works

Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels

Soni, S., Babbar, A. K., Sharma, R. K., & Maitra, A. (2006) · Journal of drug targeting · doi:10.1080/10611860600635608 · Cited by 79 · see citing works

Observations on exsudation of fibronectin, fibrinogen and albumin in the brain after carotid infusion of hyperosmolar solutions

Salahuddin, T. S., Kalimo, H., Johansson, B. B., & Olsson, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00687674 · Cited by 78 · see citing works

An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.

Manninger, S., Muldoon, L. L., Nesbit, G. M., Murillo, T. P., Jacobs, P. M., & Neuwelt, E. A. (2005) · PubMed Central · Cited by 77 · see citing works

Intrathecal chemotherapy

Kerr, J. Z., Berg, S. L., & Blaney, S. M. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00115-3 · Cited by 77 · see citing works

The in vivo delivery of heterologous proteins by microencapsulated recombinant cells

Chang, P. L. (1999) · Trends in biotechnology · doi:10.1016/s0167-7799(98)01250-5 · Cited by 75 · see citing works

Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model

Kawakami, K., Kawakami, M., Kioi, M., et al. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.101.6.1004 · Cited by 74 · see citing works

Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier

Lossinsky, A. S., VORBRODT, A. W., & Wı́sniewski, H. M. (1995) · Journal of Neurocytology · doi:10.1007/bf01191215 · Cited by 72 · see citing works

Epidermal Growth Factor Radiopharmaceuticals: 111In Chelation, Conjugation to a Blood-Brain Barrier Delivery Vector via a Biotin-Polyethylene Linker, Pharacokinetics, and in Vivo Imaging of Experimental Brain Tumors

Kurihara, A., Deguchi, Y., & Pardridge, W. M. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980123x · Cited by 71 · see citing works

Peptide-based drug design : controlling transport and metabolism

Taylor, M. D., & Amidon, G. L. (1995) · Toxicon · Cited by 70 · see citing works

Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma

Zylber‐Katz, E. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106932 · Cited by 68 · see citing works

Genetic delivery of enzymes for cancer therapy.

Deonarain, M., Spooner, R. A., & Aa, E. (1995) · PubMed · Cited by 67 · see citing works

Intracarotid administration of short‐chain alkylglycerols for increased delivery of methotrexate to the rat brain

Erdlenbruch, B., Schinkhof, C., Kugler, W., Heinemann, D. E. H., Herms, J. W., Eibl, H., & Lakomek, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705302 · Cited by 62 · see citing works

Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.

Suzuki, T., Wu, D., Schlachetzki, F., Li, J. Y., Boado, R. J., & Pardridge, W. M. (2004) · PubMed · Cited by 62 · see citing works

Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier.

Kurihara, A., & Pardridge, W. M. (1999) · PubMed · Cited by 61 · see citing works

Brain Drug Targeting and Gene Technologies

Pardridge, W. M. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.87.97 · Cited by 60 · see citing works

Controlled Release of Proteins to Tissue Transplants for the Treatment of Neurodegenerative Disorders

Mahoney, M. J., & Saltzman, W. M. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601602 · Cited by 59 · see citing works

Enhanced Disruption of the Blood Brain Barrier by Intracarotid Mannitol Injection During Transient Cerebral Hypoperfusion in Rabbits

Wang, M., Etu, J. J., & Joshi, S. (2007) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0b013e3181453851 · Cited by 57 · see citing works

A direct in vitro demonstration of insulin binding to isolated brain microvessels

Frank, H. J., & Pardridge, W. M. (1981) · Diabetes · doi:10.2337/diabetes.30.9.757 · Cited by 57 · see citing works

Vector-mediated peptide drug delivery to the brain

Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00007-t · Cited by 56 · see citing works

The Safety, Tolerability, and Pharmacokinetics of Fosphenytoin after Intramuscular and Intravenous Administration in Neurosurgery Patients

Boucher, B. A., Feler, C. A., Dean, J. C., et al. (1996) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1996.tb03646.x · Cited by 54 · see citing works

Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats

Khan, M. S., Patil, K., Yeole, P. G., & Gaikwad, R. V. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.05.0017 · Cited by 53 · see citing works

Intraarterial Delivery of Adenovirus Vectors and Liposome-DNA Complexes to Experimental Brain Neoplasms

Rainov, N. G., Ikeda, K., Nh, Q., Grover, S., Herrlinger, U., Pechan, P. A., Chiocca, E. A., Breakefield, X. O., & Barnett, F. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950019093 · Cited by 52 · see citing works

Drug Delivery Systems for Brain Tumor Therapy

Rautioa, J., & Chikhale, P. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384916 · Cited by 51 · see citing works

A new application for liposomes in cancer therapy

Vingerhoeds, M. H., Haisma, H. J., van Muijen, M., et al. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80861-n · Cited by 51 · see citing works

Assembly and Dissociation of Human Insulin and LysB28ProB29-Insulin Hexamers: A Comparison Study

Birnbaum, D. T., Kilcomons, M. A., DeFelippis, M. R., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012095115151 · Cited by 50 · see citing works

Implantable Devices for Chronic Access and Drug Delivery to the Central Nervous System

Ommaya, A. K. (1984) · Cancer Drug Delivery · doi:10.1089/cdd.1984.1.169 · Cited by 50 · see citing works

Construction and Characterization of a Fusion Protein of Single-Chain Anti-CD20 Antibody and Human β-Glucuronidase for Antibody-Directed Enzyme Prodrug Therapy

Haisma, H. J., Sernee, M. F., Hooijberg, E., et al. (1998) · Blood · doi:10.1182/blood.v92.1.184.413k26_184_190 · Cited by 49 · see citing works

Extended-Duration Analgesia: Update on Microspheres and Liposomes

Rose, J. B., Neal, J. M., & Kopacz, D. J. (2005) · Regional Anesthesia & Pain Medicine · doi:10.1016/j.rapm.2005.01.004 · Cited by 48 · see citing works

Interfacing the body’s own sensing receptors into neural prosthesis devices

Haugland, M. K., & Sinkjær, T. (1999) · Technology and Health Care · doi:10.3233/thc-1999-7603 · Cited by 46 · see citing works

Sodium dodecylsulphate induces a breach in the blood-brain barrier and enables a West Nile virus variant to penetrate into mouse brain

Kobiler, D., Lustig, S., Gozes, Y., Ben‐Nathan, D., & Akov, Y. (1989) · Brain Research · doi:10.1016/0006-8993(89)91079-2 · Cited by 46 · see citing works

The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.

Brewster, M. E., & Loftsson, Þ. (2002) · PubMed · Cited by 46 · see citing works

Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors

Abé, T., Wakimoto, H., Bookstein, R., et al. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700437 · Cited by 40 · see citing works

Neuro-oncology: the growing role of chemotherapy in glioma

Carpentier, A. F. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00944-5 · Cited by 40 · see citing works

Targeting of antiviral drugs to T4-lymphocytes

Molema, G., Jansen, R. W., Pauwels, R., et al. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90577-8 · Cited by 39 · see citing works

PPAR agonists as direct modulators of the vessel wall in cardiovascular disease

Buchan, K. W., & Hassall, D. G. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200009)20:5 · Cited by 38 · see citing works

The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis

Shubar, H. M., Dunay, I. R., Lachenmaier, S., Dathe, M., Bushrab, F. N., Mauludın, R., Müller, R. H., Fitzner, R., Borner, K., & Liesenfeld, O. (2009) · Journal of drug targeting · doi:10.1080/10611860902718680 · Cited by 37 · see citing works

Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury

Wei, G. (2007) · Frontiers in bioscience · doi:10.2741/2443 · Cited by 35 · see citing works

Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats

Erdlenbruch, B., Jendrossek, V., Kugler, W., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0497-4 · Cited by 34 · see citing works

A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo

Longman, S. A., Cullis, P. R., Choi, L. S. L., et al. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689191 · Cited by 34 · see citing works

The effect of polysorbate 80 on brain uptake and analgesic effect of D-kyotorphin

Sakane, T., Tanaka, C., Yamamoto, A., et al. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90266-4 · Cited by 32 · see citing works

Advances in antibody-directed enzyme prodrug therapy.

Sharma, S. K., Bagshawe, K. D., & Beǵent, R. H. J. (2005) · PubMed · Cited by 32 · see citing works

Simian immunodeficiency virus disrupts extended lengths of the blood–brain barrier

MacLean, A. G., Belenchia, G., Bieniemy, D. N., Moroney‐Rasmussen, T., & Lackner, A. A. (2005) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2005.00121.x · Cited by 25 · see citing works

Drug delivery to the brain utilizing blood-brain barrier transport systems

Terasaki, T., & Tsuji, A. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90132-5 · Cited by 24 · see citing works

2-Arachidonoylglycerol and Anandamide Oppositely Modulate Norepinephrine Release from the Rat Heart Sympathetic Nerves

Kurihara, J., Nishigaki, M., Suzuki, S., et al. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.87.93 · Cited by 21 · see citing works

Transport across the blood-brain barrier using albumin nanoparticles

Park, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.004 · Cited by 16 · see citing works

Controlled release formulations in neurology practice

Pandit, J., Singh, S. K., & Muthu, M. (2006) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.29202 · Cited by 14 · see citing works

Pharmacology of intrathecal VP-16-213 in dogs

Savaraj, N., Feun, L., Lu, K., et al. (1992) · Journal of Neuro-Oncology · doi:10.1007/bf00172472 · Cited by 10 · see citing works

Facile, One-Step Preparation of Trigonellinate Esters

Brewster, M. E., Venkatraghavan, V., Shek, E., et al. (1987) · Synthetic Communications · doi:10.1080/00397918708063923 · Cited by 9 · see citing works

Influx transporters and drug targeting: Application of peptide and cation transporters

Tsuji, A. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.013 · Cited by 9 · see citing works

[Transport of the hexapeptide dalargin across the hemato-encephalic barrier into the brain using polymer nanoparticles].

Аляутдин, Р. Н., Petrov, V. E., Aa, I., Kreuter, J., & Kharkevich, D. A. (1996) · PubMed · Cited by 9 · see citing works

Overcoming the Blood-Brain Barrier

(1986) · Inpharma Weekly · doi:10.1007/bf03291533 · Cited by 3 · see citing works

Direct nose to brain drug delivery <i>via</i> integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting

Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482 · see citing works

Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier

S. Hersh, D., S. Wadajkar, A., B. Roberts, N., G. Perez, J., P. Connolly, N., Frenkel, V., A. Winkles, J., F. Woodworth, G., & J. Kim, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151221150733 · Cited by 387 · see citing works

Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting

Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306 · see citing works

Nanoemulsions for “Nose-to-Brain” Drug Delivery

Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269 · see citing works

Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro

Colombo, M., Figueiró, F., de Fraga Dias, A., Teixeira, H. F., Battastini, A. M. O., & Koester, L. S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.055 · Cited by 157 · see citing works

Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route

Shah, B., Khunt, D., Misra, M., & Padh, H. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.04.076 · Cited by 112 · see citing works

Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: Formulation, behavioural and biochemical estimation

Pandey, Y. R., Kumar, S., Gupta, B. K., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/2/025102 · Cited by 96 · see citing works

Current state and future directions of intranasal delivery route for central nervous system disorders: a Scientometric and visualization analysis

Wu, H., Zhou, Y., Wang, Y., Tong, L., Wang, F., Song, S., Xu, L., Liu, B., Yan, H., & Sun, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.717192 · Cited by 90 · see citing works

PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice

Srinageshwar, B., Peruzzaro, S., Andrews, M., Johnson, K., Hietpas, A., Clark, B., McGuire, C., Petersen, E., Kippe, J., Stewart, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030628 · Cited by 91 · see citing works

Opportunities and challenges for the nasal administration of nanoemulsions

Comfort, C., Garrastazu, G., Pozzoli, M., & Sonvico, F. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150108144655 · Cited by 69 · see citing works

Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs

Nunes, D., Loureiro, J. A., & Pereira, M. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112296 · Cited by 68 · see citing works

Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)-Induced Toxicity

Yalcin, A., Soddu, E., Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Armagan, G., Rassu, G., Gavini, E., & Giunchedi, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.05.017 · Cited by 37 · see citing works

Nose-to-brain delivery of galantamine loaded nanospray dried polyacrylic acid/taurodeoxycholate mixed matrix as a protective therapy in lipopolysaccharide-induced Alzheimer’s in mice model

Elhabak, M., Salama, A. A. A., & Salama, A. H. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122588 · Cited by 27 · see citing works

Physical Properties of Materials for Engineers

Pollock, D. D. (2018) · CRC Press eBooks · doi:10.1201/9781351075619 · Cited by 101 · see citing works

BACE-1 is expressed in the blood–brain barrier endothelium and is upregulated in a murine model of Alzheimer’s disease

Devraj, K., Poznanović, S., Spahn, C. K., Schwall, G., Harter, P. N., Mittelbronn, M. G. A., Antoniello, K., Paganetti, P., Muhs, A., Heilemann, M., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15606463 · Cited by 72 · see citing works

Modeling the Blood–Brain Barrier to Understand Drug Delivery in Alzheimer’s Disease

Wasielewska, J. M., Chaves, J., White, A. R., & Oikari, L. E. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch7 · Cited by 13 · see citing works

Blood-brain barrier and new approaches to brain drug delivery.

Pardridge, W. M., Boado, R. J., Black, K. L., & Cancilla, P. A. (1992) · PubMed Central · Cited by 39 · see citing works

Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?

Löscher, W., & Gericke, B. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100966 · Cited by 40 · see citing works